Ovid Therapeutics
Develops targeted small molecules for neurological disorders involving neuronal hyperexcitability.
$2.81
After-hours close0.00 (0.00%)
At close$2.81(−4.10%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.12 | −$0.08 | +30.4% |
| Aug 2026 | −$0.10 | −$0.08 | +20.0% |
| May 2026 | −$0.12 | −$0.12 | 0.0% |
| Mar 2026 | −$0.10 | $0.06 | +160.0% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Jun 2017 | |||
| May 2017 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.09 | — | — | $20.3K | — | — |
| Aug 13, 2026 | −$0.12 | −$0.08 | +30.4% | $21.4K | $733.0K | +3,320.6% |
| Aug 12, 2026 | −$0.10 | −$0.08 | +20.0% | $21.4K | $733.0K | +3,320.6% |
| May 12, 2026 | −$0.12 | −$0.12 | 0.0% | $56.7K | — | — |
| Mar 18, 2026 | −$0.10 | $0.06 | +160.0% | $78.3K | $718.0K | +817.6% |
The latest year is open to everyone — the 40 quarters behind it read with an account. Sign in | ||||||
| Nov 12, 2025 | ||||||
| Aug 13, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 11, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 8, 2024 | ||||||
| Nov 3, 2023 | ||||||
| Aug 4, 2023 | ||||||
| May 5, 2023 | ||||||
| Mar 13, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 15, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 16, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 15, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 11, 2020 | ||||||
| Nov 8, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 7, 2019 | ||||||
| Mar 7, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 29, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 10, 2017 | ||||||
| Jun 13, 2017 | ||||||
| May 5, 2017 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||